Effect of the Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia

NCT00502047 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 255

Last updated 2007-07-17

No results posted yet for this study

Summary

The hypothesis of this study is that soluble fibre may contribute to a reduction of the low density lipoprotein cholesterol (LDL-c), and the combined effect with a statin may achieve an optimisation of the cholesterol-lowering effects in adults with several cardiovascular risk factors.

Conditions

Interventions

DRUG

Plantago ovata husk

Sponsors & Collaborators

  • Rottapharm Spain

    lead INDUSTRY

Principal Investigators

  • Rosa Solà, MD, phD · Hosp. Universitario San Joan de Reus , Spain

  • Manuel Castro, MD, phD · Hosp. Saint Franciscus Gasthuis, Rotterdam (Netherlands)

  • Eric Brucker, MD, phD · Hosp. de la Pitié, Paris (France)

  • Mª Cruz Almaraz, MD · Hosp. Universitario Carlos Haya, Málaga (Spain)

  • Xavier Luque, MD · Centro de Atención Primaria Alcover, Tarragona (Spain)

  • José Vicente Vaquer, MD · Centro de Salud Petrer I, Alicante (Spain)

  • Luis de Teresa, MD · Hosp. San Vicente de Raspeig, Alicante (Spain)

  • Silvia Narejos, MD · Centro de Atención Primaria Centelles, Barcelona (Spain)

  • Xavier Farrés, MD · Centro de Atención Primaria El Remei, Vic, Barcelona (Spain)

  • José Miguel Martínez, MD · Centro de Salud Tomás Ortuño, Benidorm, Alicante (Spain)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2007-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00502047 on ClinicalTrials.gov